Time for a "Third Wave" of malaria activism to tackle the drug stock-out crisis.

PubWeight™: 1.86‹?› | Rank: Top 3%

🔗 View Article (PMC 2771762)

Published in PLoS Med on November 24, 2009

Articles cited by this

WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet (2004) 9.27

The burden of malaria mortality among African children in the year 2000. Int J Epidemiol (2006) 6.64

Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med (2009) 4.49

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Malar J (2007) 4.21

International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med (2008) 3.86

Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar J (2008) 3.73

Roll Back Malaria: a failing global health campaign. BMJ (2004) 3.71

A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg (2007) 3.38

Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One (2009) 3.11

Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Am J Trop Med Hyg (2009) 2.84

Roll back malaria? The scarcity of international aid for malaria control. Malar J (2003) 2.17

The malaria gap. Am J Trop Med Hyg (2004) 1.86

Focusing on quality patient care in the new global subsidy for malaria medicines. PLoS Med (2009) 1.63

Global fund changes tack on malaria therapy. Nature (2004) 0.91

Malaria researchers say global fund is buying "useless drug". BMJ (2003) 0.85

Health agencies end in-fighting on malaria. BMJ (2004) 0.84

Divergent goals and commitments in global malaria intervention. PLoS Med (2008) 0.84